Quantum-Si, a protein sequencing platform, offers semiconductor chips designed to enable single-molecule next-generation protein sequencing and genomics and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.
Over the past year, investors have posted confidence in the company’s prospects, as reflected in a 100-percent increase in its 52-week price to $4.10 per share.
Its earnings performance is also beginning to reflect its growth potential, with quarterly revenues soaring by 252.9 percent year-on-year to $787,000 while gross profit similarly rose by 239 percent during the same period.